EU drug regulator finds 'possible link' between AstraZeneca vaccine and rare clots; says benefits still outweigh risks

EU drug regulator finds 'possible link' between AstraZeneca vaccine and rare clots; says benefits still outweigh risks

AMSTERDAM -- EU drug regulator finds 'possible link' between AstraZeneca vaccine and rare clots; says benefits still outweigh risks.